WallStSmart
EXAS

EXACT Sciences Corporation

NASDAQ: EXAS · HEALTHCARE · DIAGNOSTICS & RESEARCH

$104.91
+0.00% today

Updated 2026-03-24

Market cap
$20.03B
P/E ratio
P/S ratio
6.17x
EPS (TTM)
$-1.10
Dividend yield
52W range
$39 – $1,878
Volume
2.7M

EXACT Sciences Corporation (EXAS) Financial statements

SEC filings — annual and quarterly data.

Balance sheet — annual

Item20052006200720082009201020112012201320142015201620172018201920202021202220232024
Total assets$37.84M$23.87M$14.60M$5.90M$25.77M$96.52M$96.95M$112.12M$146.63M$311.62M$364.30M$377.04M$598.56M$1.52B$3.51B$4.93B$6.68B$6.23B$6.47B$5.93B
Cash & equivalents
Current assets$35.28M$21.46M$12.86M$5.13M$25.31M$95.66M$94.39M$108.71M$135.46M$291.68M$326.13M$333.57M$487.22M$1.23B$553.94M$2.20B$1.43B$982.26M$1.19B$1.57B
Total liabilities$13.22M$8.91M$8.31M$8.33M$19.68M$16.76M$13.46M$13.52M$11.31M$22.64M$37.44M$41.74M$78.14M$843.08M$1.22B$2.69B$3.30B$3.18B$3.33B$3.53B
Current liabilities$6.32M$6.37M$4.41M$5.03M$6.53M$7.16M$7.98M$11.46M$7.75M$17.52M$26.72M$30.69M$68.12M$136.59M$236.49M$633.10M$517.07M$412.75M$514.70M$732.19M
Long-term debt$1.00M$1.00M$1.00M$1.71M$1.36M$1.00M$4.79M$4.63M$4.27M$688.82M$827.64M$1.34B$2.18B$2.19B$2.31B$2.32B
Shareholder equity
Retained earnings$-137.85M$-150.76M$-162.72M$-172.47M$-181.59M$-193.15M$-221.82M$-274.25M$-320.76M$-420.81M$-578.61M$-745.82M$-860.61M$-1.04B$-1.12B$-2.05B$-2.64B$-3.27B$-3.47B$-4.50B
Accounts receivable$1.38M$4.93M$8.53M$26.42M$44.24M$130.36M$233.19M$216.65M$158.04M$203.62M$248.97M
Inventory$0.00$0.00$0.00$4.02M$6.68M$6.83M$26.03M$39.15M$61.72M$92.27M$104.99M$118.26M$127.47M$162.38M
Goodwill$1.42M$763000.00$432000.00$95000.00$0.00$0.00$0.00$0.00$0.00$0.00$22.16M$17.28M$1.20B$1.24B$2.34B$2.35B$2.37B$2.37B